69097-262 : Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 69097-262 |
Labeler: | Cipla USA Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Topotecan Hydrochloride |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | ANDA091199 |
Rev. Date: |
NDC Package Codes:
- 69097-262-67: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (69097‑262‑67) > 4 ML IN 1 VIAL, SINGLE‑DOSE
- 69097-262-68: 5 VIAL, SINGLE‑DOSE IN 1 CARTON (69097‑262‑68) > 4 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Topotecan Hydrochloride
Dosage Strength:
- 4 mg/4mL
Pharmaceutical Classes:
- Topoisomerase Inhibitor [EPC]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0069-0075 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
- 16729-151 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
- 25021-206 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
- 25021-824 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
- 45963-615 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
- 55390-370 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
- 62756-023 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
- 63323-762 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
- 66435-410 Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, for Solution by Three Rivers Pharmaceuticals, LLC.
- 67457-474 Topotecan Hydrochloride 4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 69097-261Next: 69097-263 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.